GARDASIL®9 (Human Papillomavirus 9-Valent Vaccine, Recombinant 9vHPV) in prevention of Cervical Cancer in Adolescent Females. [PDF]
, 2021 Purpose: This study aims to prove the significance of early GARDASIL®9 vaccination in adolescent females before exposure to HPV and targeting all ethnic groups in HPV awareness.
Leriche, Rose-Marie P
core
Fallbericht: Verlauf einer AORRP unter PEP mit Gardasil® [PDF]
, 2017 Hintergrund: Die rezidiverende respiratorische Papillomatose des Erwachsenen (englisch - adult-onset recurrent respiratory papillomatosis/AORRP) mit Befall des Larynx ist eine seltene, durch Infektion mit humanen Papillomaviren (HPV) der Typen 6 oder 11
Wittekindt, C, Klußmann, JP, Döring, L
core +1 more source
A Critical Discourse Analysis of the Marketing of Merck & Co.\u27s Human Papillomavirus Vaccine Gardasil® [PDF]
, 2011 This is a critical discourse analysis research project that examines the print and television advertisements of Merck & Co.’s Human Papillomavirus (HPV) vaccine GARDASIL®.
Redmond, Malika A
core +2 more sources
Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine [PDF]
, 2019 Bivalent (Cervarix®) and quadrivalent (Gardasil®) Human Papillomavirus (HPV) vaccines demonstrate remarkable efficacy against the targeted genotypes, HPV16 and HPV18, but also a degree of cross-protection against non-vaccine incorporated genotypes, HPV31
Andrews, N +8 more
core +1 more source
Distribution of anal HPV types included (or not included) in the 9-valent Gardasil-9® vaccine. [PDF]
, 2018 Number of low-risk (LR) and high-risk (HR) HPV genotypes in 29 anal swabs positive for HPV DNA by molecular biology according to their possible prevention by 9-valent HPV vaccine among study men who have sex with men (n = 42) living in the Central ...
Jean De Dieu Longo (4574164) +11 more
core +1 more source
Characterisation of serological and cell-mediated immunity in RRP patients after immunisation with the prophylactic HPV vaccine Gardasil® [PDF]
, 2016 Die rezidivierende respiratorische Larynxpapillomatose (RRP) gehört zu den häufigsten benignen Erkrankungen des Larynx. Sie wird je nach Alter bei Erstdiagnose in eine juvenile und eine adulte Form gegliedert.
Wittchen, Tanja Vanessa (geb. Fromm)
core +1 more source
Frontiers in Cellular and Infection Microbiology, 2019 Aim: This study aimed to follow the impact of human papillomavirus (HPV) catch-up and vaccination on the very high cervical HPV-prevalence in women at a youth clinic in central Stockholm during the period 2008–2018.Background: 2008–2010, cervical HPV ...
Andreas Ährlund-Richter +15 more
doaj +1 more source
BMC Infectious Diseases, 2018 Background Recurrent respiratory papillomatosis (RRP) is a rare, benign disease of the aerodigestive tract, especially the larynx, caused by infection with the human papillomavirus (HPV) types 6 or 11.
Paul Stefan Mauz +3 more
doaj +1 more source
Papillomavirus Research, 2020 Human papillomavirus (HPV) causes not only most cervical cancers but also cancers of the vagina, vulva, penis, anus, rectum, and oropharynx. Every year, 200,000 women die of cervical cancer in the world, and China accounts for about 10%. HPV vaccines are
Yan Wang +5 more
doaj +1 more source
Modélisation numérique des aspects immunologiques de la réaction à l’infection à HPV et de la vaccination anti-HPV par Gardasil® [PDF]
, 2011 Two prophylactic vaccines have demonstrated to prevent infections with the human papillomavirus (HPV). Thus, they have been in the market for the last four years, or so.
Olivera-Botello, Gustavo
core +6 more sources